Hybrid EMT Phenotype and Cell Membrane Tension Promote Colorectal Cancer Resistance to Ferroptosis
Advanced Science · 2025
DOI: 10.1002/advs.202413882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaowei Wei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China. Hauptthemen laut MEDLINE: Ferroptosis, Epithelial-Mesenchymal Transition, Colorectal Neoplasms, Cell Membrane. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Hong Kong Research Grant Council.
Abstract (Originalsprache)
Intratumoral heterogeneity, including epithelial–mesenchymal transition (EMT), is one major cause of therapeutic resistance. The induction of ferroptosis, an iron‐dependent death, has the potential in overcoming this resistance to traditional treatment modalities. However, the roles of distinct EMT phenotypes in ferroptosis remain an enigma. This study reports that 3D soft fibrin microenvironment confers colorectal cancer (CRC) cells hybrid EMT phenotype and high level of resistance to ferroptosis. The activation of histone acetylation and WNT/β‐catenin signaling drives this EMT phenotypic transition, which promotes the defense of 3D CRCs against ferroptosis via glutathione peroxidases/ferritin signaling axis. Unexpectedly, E‐cadherin knockout in 3D but not 2D CRCs mediates an integrin β 3 marked‐late hybrid EMT state and further enhances the resistance to ferroptosis via integrin‐mediated tension and mitochondrial reprogramming. The inhibition of integrin α v β 3 ‐mediated tension and WNT/β‐catenin‐mediated hybrid EMT sensitizes 3D CRCs with and without E‐cadherin deficiency to ferroptosis in vivo, respectively. Further, the EMT phenotype of patient‐derived tumoroids is associated with CRC therapeutic resistance. In summary, this study uncovers previously unappreciated roles of hybrid EMT and cell membrane tension in ferroptosis, which not only predict the treatment efficacy but also potentiate the development of new ferroptosis‐based targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
- Department of Respiratory, Critical Care and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
- Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- School of Medicine, Southeast University, Nanjing, 210009, China.
- Guangzhou National Laboratory, Guangzhou, 510005, China.
ORCID-Profile: Qiong Jia
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Hong Kong Research Grant Council
- Shenzhen Science and Technology Innovation Program
- Health and Medical Research Fund
Zitieren
APA
Wei, X., Ge, Y., Zheng, Y., Zhao, S., Zhou, Y., Chang, Y., Wang, N., Wang, X., Zhang, J., Zhang, X., Hu, L., Tan, Y., & Jia, Q. (2025). Hybrid EMT Phenotype and Cell Membrane Tension Promote Colorectal Cancer Resistance to Ferroptosis. Advanced Science. https://doi.org/10.1002/advs.202413882
Vancouver
Wei X, Ge Y, Zheng Y, Zhao S, Zhou Y, Chang Y, et al. Hybrid EMT Phenotype and Cell Membrane Tension Promote Colorectal Cancer Resistance to Ferroptosis. Advanced Science. 2025. doi:10.1002/advs.202413882
BibTeX
@article{Wei2025,
author = {Wei, Xiaowei and Ge, Yutong and Zheng, Yaolin and Zhao, Sunyan and Zhou, Yuhan and Chang, Yuhan and Wang, Nuofan and Wang, Xiumei and Zhang, Juan and Zhang, Xuanchang and Hu, Liqiao and Tan, Youhua and Jia, Qiong},
title = {Hybrid EMT Phenotype and Cell Membrane Tension Promote Colorectal Cancer Resistance to Ferroptosis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202413882}
}
EUVIMED